article thumbnail

MediPharm Labs Enters United States Pharmaceutical Market with Submission of FDA DMF

Cannabis Law Report

(TSX: LABS) (OTCQX: MEDIF ) (FSE: MLZ) (“MediPharm” or the “Company”) a pharmaceutical company specialized in precision-based cannabinoids, is pleased to announce it has completed a US FDA DMF for pure natural CBD API. The DMF will enable MediPharm to supply approved API to pharmaceutical companies currently conducting late-stage research.

article thumbnail

Flora Growth Completes Successful First Cannabis Extraction Through New Facility, Initiates EU-GMP Certification Process

Cannabis Law Report

Flora’s cultivation and extraction division, Cosechemos, completed construction of a 10,500 ft 2 state-of-the-art post-harvest and extraction facility with annual capacity of 15,000 L of distillate. At this time, the team is continuing commercial CBD extraction.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

International Cannabis to Supply New Zealand’s NUBU Pharmaceuticals With Portfolio of Full-Spectrum Pharmaceutical THC/CBD Products

Cannabis Law Report

FWB: 8K51)(OTC: WLDCF) (the “Company” or “ ICC ” or “ International Cannabis”) is pleased to announce that the Company has entered into an exclusive supply and commercial rights agreement (the “Agreement”) with licensed New Zealand medical cannabis company, NUBU Pharmaceuticals (“NUBU”). (CSE: WRLD.U)(FWB:

article thumbnail

International Cannabis to Supply New Zealand’s NUBU Pharmaceuticals With Portfolio of Full-Spectrum Pharmaceutical THC/CBD Products

Cannabis Law Report

FWB: 8K51)(OTC: WLDCF) (the “Company” or “ ICC ” or “ International Cannabis”) is pleased to announce that the Company has entered into an exclusive supply and commercial rights agreement (the “Agreement”) with licensed New Zealand medical cannabis company, NUBU Pharmaceuticals (“NUBU”). (CSE: WRLD.U)(FWB:

article thumbnail

Radicle Science and Open Book Extracts Announce New Alliance to Advance Consumer Trust and CBD Industry Validation

Cannabis Law Report

Step four: Brands select packaging, labels and other physical concepts for the selected product in a fully customizable experience. Join Us in Advancing Cannabis Science to Elevate the Industry , by Pelin Thorogood, Co-founder and Executive Chair of Radicle Science, and Nicole Brown, Chief Innovation Officer of Open Book Extracts.

article thumbnail

Flora Growth Launches Cutting-Edge Global Cannabis Distribution Strategy, Implements Pharmaceutical Standards For Its Supply Chain

Cannabis Law Report

Flora will now have the ability to quickly and efficiently reference and manage information at its cultivation and extraction facility, collect and analyze data, derive insights to find cost efficiencies, and ensure accuracy. MIAMI & TORONTO–(BUSINESS WIRE)–Flora Growth Corp. Warrant Exercise Update.

article thumbnail

THC Global ready to manufacture medicinal cannabis with receipt of final licence

Cannabis Law Report

The GMP Licence is recognised for supply of pharmaceutical goods in 29 countries across Europe, Asia, and Canada, and authorises the company to manufacture Active Pharmaceutical Ingredient extracts; formulation and packaging of medicines; on-site testing and analysis; and supply of medicinal cannabis for human trials in Australia and globally.